Concordantly, we showed that treatment with recombinant proteins (500 pg/mL MCP-1 in H1299 and 1000 pg/mL IL-6 in H358) significantly restored the anti-cancer effects caused by Hiltonol (Figure 4H). This evidence concerns the gene IL6 and cancer.